GADOR SA

Overview

GADOR SA is an active pharmaceutical ingredient (API) supplier with 5 active FDA Type II Drug Master Files, covering 17-DEACETYL NORGESTIMATE; NORGESTIMATE- DEXNORGESTREL ACETIME; PAMIDRONATE DISODIUM; PAMIDRONIC ACID; ZOLEDRONIC ACID.

API / Drug Master Files

GADOR SA holds 5 active (11 total) FDA Type II Drug Master Files — identifying it as an active-substance / API supplier. Type II DMFs are filed with the FDA to support the use of an active pharmaceutical ingredient in drug applications.

• PAMIDRONATE DISODIUMActive2025-09-30
• ZOLEDRONIC ACIDActive2009-12-16
• 17-DEACETYL NORGESTIMATEActive2006-11-30
• NORGESTIMATE- DEXNORGESTREL ACETIMEActive2002-11-26
• PAMIDRONIC ACIDActive1999-10-22
• DUTASTERIDEInactive2010-05-18
• SODIUM IBANDRONATEInactive2009-12-08
• SODIUM ALENDRONATEInactive2009-04-17
• ZALEPLONInactive2005-12-13
• VENLAFAXINE HYDROCHLORIDEInactive2004-10-12
• ZOLPIDEM HEMITARTRATEInactive1994-01-10

FDA compliance signals

No FDA recalls, Warning Letters, or Form 483 observations are linked to GADOR SA in our records. PharmaTek screens the full directory against live FDA enforcement data.